Troriluzole

Generic Name: Troriluzole

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₁₆F_₃N_₅O_₄S

CAS Number: 1926203-09-9

Unique Ingredient Identifier: S7H48S6K7H

Background: Troriluzole is under investigation in clinical trial NCT03701399 (Troriluzole in Adult Subjects With Spinocerebellar Ataxia).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Phase 3

Recruiting

Conditions: Obsessive-Compulsive Disorder

Interventions: Drug: Troriluzole
Drug: Placebo

First Posted Date: 2020-11-23

Last Posted Date: 2025-01-09

Lead Sponsor: Biohaven Pharmaceuticals, Inc.

Target Recruit Count: 700

Registration Number: NCT04641143

Locations: 🇺🇸
Global Clinical Trials, Costa Mesa, California, United States
🇺🇸
Hassman Research Institute, Berlin, New Jersey, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 82 locations

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy